The Intersection Between Genomics and New Therapies in Advanced Prostate Cancer

This video is a recording of Prostate Cancer Foundation Canada's Coast to Coast Support Group meeting held over Zoom.
Dr. Sofie Tolmeijer and Dr. Edmond Kwan from the Vancouver Prostate Centre discuss how tumour DNA testing and germline (genes inherited from one’s parents) testing will play an increasingly important role in selecting patients for new precision therapies.
---
For more information on Prostate Cancer Foundation Canada (formerly Prostate Cancer Foundation BC), a nonprofit proudly providing leadership and resources in prostate cancer support, awareness, and research since 1997, please visit: prostatecanada.ca
The views, information, and opinions expressed in this video are those of the individuals involved and do not necessarily reflect the official policy or position of Prostate Cancer Foundation Canada (PCFC) or its employees. PCFC is not responsible and does not verify for accuracy any of the information contained in the videos available for watching on this site. The primary purpose of these videos is to educate and inform, but these videos do not constitute, or replace, medical or other professional advice.